What is BTIG's price target for RXST?

BTIG's latest stated price target for RxSight Inc. (RXST) is $72, from its action on May 7, 2024.

What is BTIG's rating on RXST?

BTIG rates RXST Neutral, a neutral rating, as of Jul 9, 2025.

When did BTIG last change its view on RXST?

On Jul 9, 2025, BTIG downgrades to Neutral from Buy.

BTIG RXST price target and rating history

BTIG rates RxSight Inc. (RXST) Neutral with a $72 price target, as of its latest action on Jul 9, 2025. It has published 3 rating actions on RXST since August 2021, including 0 upgrades and 1 downgrade.

Current rating: Neutral
Price target: $72
Median target, all firms: Too few
Actions on RXST: 3

BTIG price target on RXST

BTIG price target on RXST, each point a stated target, August 2021 to May 2024.

Every BTIG rating on RXST

Jul 9, 2025
DowngradeBTIG downgrades to Neutral from Buy
May 7, 2024
ReiterateBTIG raises its price target to $72 from $61, keeps Buy
Aug 24, 2021
InitiateBTIG starts coverage at Buy, price target $28

Questions about BTIG and RXST

What is BTIG's price target for RXST?: BTIG's latest stated price target for RxSight Inc. (RXST) is $72, from its action on May 7, 2024.
What is BTIG's rating on RXST?: BTIG rates RXST Neutral, a neutral rating, as of Jul 9, 2025.
When did BTIG last change its view on RXST?: On Jul 9, 2025, BTIG downgrades to Neutral from Buy.

More RXST rating histories

All BTIG ratings RXST news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.